What TBB Funds

What We Fund

In the last five years we’ve funded the following:

2025  Projected $1,000,000
$200,000Cellular Therapy
$200,000Microbiome Research
$100,000AI.ONCOCURE
$200,000The Breakthrough Board Team Science Award
$100,000Ben May Department of Cancer Research
$100,000Young Investigator Award
$50,000Pedriatric Brain Cancer Research Grant
TBDTBD Breast Cancer Research Grant
2024$1,000,000
$200,000Cancer Center Microbiome Core
$125,000Leading-Edge Therapies for Solid Tumors
$125,000Theranostics Research Support
$100,000Argonne Collaborative
$100,000Cancer Metabolomics R&D
$100,000Spatial Transcriptomics Research
$100,000Young Investigator Award
$50,000Ben May Department of Cancer Research
$50,000Committee on Cancer Biology Graduate Program
$50,000“Near The Payline” NCI Grant Applications

  
2023$1,050,000
$100,000Young Investigator Award
$150,000Clinicial Pipeline Enabling Award
$100,000Argonne Collaborative
$100,000Medicinal Chemistry R&D
$150,000Immunoengineering R&D
$150,000IND Enabling Studies
$150,000The Breakthrough Board Team Science Grant
$100,000Ben May Department of Cancer Research
$50,000“Near the Payline” NCI Grant Application
2022$1,050,000
$50,000Young Investigator Award
$150,000Cancer Metobolomics Core Facility
$150,000Ben May Department for Cancer Research
$125,000TGRE
$100,000Colorectal Cancer Immunotherapy
$100,000Improving Quality of Life and Outcomes for Head and Neck Cancer Patients
$100,000Head and Neck Cancer Biomarker-driven HPV de-escalation therapy
$100,000Identification of Solid Tumor Target for Women’s Cancer
$100,000Head and Neck Cxancer ATRA enchances effects of radiotherapy and immunotherapy
$75,000Community Impact – Cervical Cancer
2021  $270,000 (limited funding due to Covid-19)
$70,000Personalized Cancer Treatments
$100,000Spotlight: Leveraging AI/ Data to Understand, Diagnose and Treat Cancer
$100,000Spotlight: Tumor Biology – Metabolism